Cargando…
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Lysine-specific demethylase 5B (KDM5B/PLU1/JARID1B) is found to be overexpressed in numerous malignancies, including breast, lung, skin, liver, and prostate cancer. Identification of molecules targeting the KDM5B enzyme could be a potential lead in cancer research. Although many KDM5B inhibitors wit...
Autores principales: | Jose, Anmi, Shenoy, Gautham G., Sunil Rodrigues, Gabriel, Kumar, Naveena A. N., Munisamy, Murali, Thomas, Levin, Kolesar, Jill, Rai, Ganesha, Rao, Praveen P. N., Rao, Mahadev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465382/ https://www.ncbi.nlm.nih.gov/pubmed/32751840 http://dx.doi.org/10.3390/cancers12082121 |
Ejemplares similares
-
Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective
por: Jose, Anmi, et al.
Publicado: (2020) -
Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges
por: Kumar, Naveena A. N., et al.
Publicado: (2021) -
KDM5 histone demethylases repress immune response via suppression of STING
por: Wu, Lizhen, et al.
Publicado: (2018) -
The Histone Demethylase KDM5 Is Essential for Larval Growth in Drosophila
por: Drelon, Coralie, et al.
Publicado: (2018) -
The nuclear bodies formed by histone demethylase KDM7A
por: Ming, Hui, et al.
Publicado: (2020)